Dimebon (latrepirdine)

DRUG2 trials

Sponsors

Medivation, Inc.

Conditions

Huntington DiseaseModerate to Severe Alzheimer

Phase 3

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

TerminatedNCT00954590

Medivation, Inc.Moderate to Severe Alzheimer

Start: 2009-10-31Updated: 2016-09-27

An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease

TerminatedNCT01085266

Medivation, Inc.Huntington Disease

Start: 2010-02-28Updated: 2016-10-12